c peptide in factitious hypoglycemia provides a valuable tool in the diagnosis of fasting hypoglycemia - Surreptitioushypoglycemia factitious

Factitious hypoglycemiavs insulinoma C-Peptide: A Key Indicator in Diagnosing Factitious Hypoglycemia

Factitious hypoglycemia, a condition where individuals intentionally induce low blood sugar levels, presents a diagnostic challenge. A crucial tool in differentiating this self-induced condition from other causes of hypoglycemia, such as insulinoma, is the measurement of C-peptide. C-peptide, a byproduct of insulin production, plays a vital role in understanding the body's endogenous insulin secretion and distinguishing it from exogenous insulin administration. When hypoglycemia is present, analyzing C-peptide levels alongside insulin levels can provide definitive clues to the underlying cause, particularly in cases of suspected factitious hypoglycemia.

Understanding C-Peptide and Its Role in Hypoglycemia

C-peptide is a small protein fragment that is cleaved from proinsulin to form mature insulin作者：JA Scarlett·1977·被引用次数：178—Determination of plasma freeC-peptideand free insulin permitted patients with high titers of insulin antibodies, including those with a .... Both insulin and C-peptide are stored in the pancreas and released into the bloodstream in equimolar amounts when the body needs to regulate blood glucose. Therefore, in individuals with normal endogenous insulin production, elevated insulin levels are typically accompanied by proportionally elevated C-peptide levels.

However, this relationship changes dramatically in factitious hypoglycemia. When an individual surreptitiously administers exogenous insulin (synthetic insulin not produced by their own body), their blood insulin levels rise, but their pancreas does not increase its own insulin production.作者：M Yukina·2022·被引用次数：7—When human insulin is administered, insulin levels increase whileC-peptideand proinsulin levels become suppressed because exogenous insulin ... Consequently, C-peptide levels remain low or undetectable2025年8月6日—...hypoglycemiawith lowC-peptidelevels, findings which confirmed a diagnosis offactitious hypoglycemia. Surreptitious administration of .... This discrepancy between high insulin and low C-peptide is a hallmark of factitious hypoglycemia caused by exogenous insulin injection.

Conversely, in conditions like insulinoma, a tumor of the pancreas that secretes excess insulin, both insulin and C-peptide levels will be elevated, reflecting the body's own overproduction of insulinSurreptitious ingestion of sulfonylurea could causehypoglycemiaalong with high insulin andC-peptidelevels since the drugs stimulate pancreatic insulin ....

Distinguishing Factitious Hypoglycemia: C-Peptide as a Diagnostic Marker

The diagnostic utility of C-peptide in factitious hypoglycemia is well-established. When a patient presents with symptoms of hypoglycemia, simultaneous measurement of serum insulin and C-peptide levels during a hypoglycemic episode is essential.

* Factitious Hypoglycemia due to Exogenous Insulin: In this scenario, a finding of elevated serum insulin levels with low or undetectable C-peptide levels strongly suggests the administration of exogenous insulin. This is because the injected insulin does not stimulate the pancreas to produce C-peptide.

* Factitious Hypoglycemia due to Sulfonylureas: Another form of factitious hypoglycemia involves the surreptitious ingestion of sulfonylurea medications. These drugs stimulate the pancreas to release its own insulin. Therefore, in sulfonylurea-induced factitious hypoglycemia, both insulin and C-peptide levels will be elevated.作者：JA Scarlett·1977·被引用次数：178—Both immunoreactive insulin andC-peptidemay thus be spuriously elevated in patients with insulin antibodies and complicate the assessment of ... However, this can be distinguished from an insulinoma by other clinical factors and specific pharmacokinetic profiles of the drug.C-Peptide in Factitious Hypoglycemia from Sulfonylurea

* Insulinoma: In contrast, an insulinoma, a benign tumor of the pancreas, will lead to inappropriately high levels of both insulin and C-peptide, as the tumor autonomously secretes insulin.2005年7月1日—This investigation was performed duringhypoglycemiaand revealed high insulin levels and undetectableC-peptidelevels, suggestingfactitious...

The Insulin-to-C-Peptide Ratio

In some cases, the ratio of insulin to C-peptide can also provide valuable diagnostic information. A significantly elevated insulin-to-C-peptide ratio (often cited as greater than 1.0, although specific thresholds may vary) can be indicative of exogenous insulin administration, further supporting a diagnosis of factitious hypoglycemiaThis investigation was performed during hypoglycemia and revealed high insulin levels andundetectable C-peptide levels, suggesting factitious hypoglycemia..

Challenges and Considerations

While C-peptide measurement is a powerful diagnostic tool, there are complexities to consider:

* Insulin Antibodies: In patients with diabetes who are treated with insulin, the presence of insulin antibodies can sometimes interfere with the interpretation of insulin and C-peptide levels. These antibodies can bind to insulin, leading to spuriously elevated measured insulin levels and potentially complicating the assessment. However, C-peptide is generally less affected by these antibodies作者：C COUROPMITREE·1975·被引用次数：53—Plasma C-Peptide and Diagnosis of Factitious Hyperinsulinism: Study of an Insulin-Dependent Diabetic Patient with "Spontaneous" Hypoglycemia..

* Timing of Measurement: It is crucial to obtain blood samples for C-peptide and insulin measurement *during* a hypoglycemic episode2005年7月1日—This investigation was performed duringhypoglycemiaand revealed high insulin levels and undetectableC-peptidelevels, suggestingfactitious.... Measuring these markers when blood glucose levels are normal may not reveal the underlying problem作者：G Dimitriadis·1980·被引用次数：13—Estimation of immunologically measurable insulin duringhypoglycemiaafter an overnight fast revealed high values, while simultaneous determination of serumC- ....

* Renal Function: C-peptide is cleared by the kidneys. While it has a lower metabolic clearance rate than insulin, impaired renal function could theoretically affect C-peptide levels, though this is usually not a primary confounder in the diagnosis of factitious hypoglycemia.C-Peptide in Factitious Hypoglycemia from Sulfonylurea

Conclusion

The measurement of C-peptide is indispensable in the diagnostic workup of factitious hypoglycemia. By assessing the relationship between insulin and C-peptide levels during hypoglycemic episodes, clinicians can effectively distinguish between endogenous insulin production (as seen in insulinoma or normal physiological responses) and exogenous insulin administration or the effects of insulin secretagogues like sulfonylureasFactitious Hypoglycemia - MD Searchlight. This distinction is critical for appropriate patient management and for addressing the underlying psychological or behavioral issues that drive factitious hypoglycemia. The validity of C-peptide measurement in the diagnosis of factitious hypoglycemia remains a cornerstone of endocrinology, providing a clear signal where other indicators might be misleading.